JFrog (FROG) 10-Q 10 May 24 2024 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Mar. 31, 2024	May 03, 2024
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Entity Registrant Name	JFrog Ltd.
Entity Central Index Key	0001800667
Entity File Number	001-39492
Entity Tax Identification Number	98-0680649
Document Quarterly Report	true
Document Transition Report	false
Entity Incorporation, State or Country Code	L3
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Interactive Data Current	Yes
Entity Current Reporting Status	Yes
Entity Address, Address Line One	270 E. Caribbean Drive
Entity Address, City or Town	Sunnyvale
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94089
City Area Code	408
Local Phone Number	329-1540
Entity Shell Company	false
Entity Small Business	false
Entity Emerging Growth Company	false
Title of 12(b) Security	Ordinary Shares, NIS 0.01 par value
Trading Symbol	FROG
Security Exchange Name	NASDAQ
Entity Common Stock, Shares Outstanding		108,420,032

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 71,385	$ 84,765
Short-term investments	508,229	460,245
Accounts receivable, net	66,570	76,437
Deferred contract acquisition costs	11,869	11,378
Prepaid expenses and other current assets	17,569	12,976
Total current assets	675,622	645,801
Property and equipment, net	6,473	6,663
Deferred contract acquisition costs, noncurrent	17,727	18,032
Operating lease right-of-use assets	20,323	22,427
Intangible assets, net	22,879	25,768
Goodwill	247,955	247,955
Other assets, noncurrent	6,101	5,910
Total assets	997,080	972,556
Current liabilities:
Accounts payable	14,247	16,970
Accrued expenses and other current liabilities	39,597	35,815
Operating lease liabilities	8,135	8,272
Deferred revenue	198,240	201,118
Total current liabilities	260,219	262,175
Deferred revenue, noncurrent	12,972	12,987
Operating lease liabilities, noncurrent	11,705	13,954
Other liabilities, noncurrent	4,382	4,317
Total liabilities	289,278	293,433
Commitments and contingencies (Note 10)
Shareholders' equity:
Preferred shares, NIS 0.01 par value per share; 50,000,000 shares authorized; 0 issued and outstanding as of March 31, 2024 and December 31, 2023	0	0
Ordinary shares, NIS 0.01 par value per share, 500,000,000 shares authorized; 108,338,295 and 106,114,892 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	303	297
Additional paid-in capital	1,006,865	968,245
Accumulated other comprehensive income (loss)	(144)	1,013
Accumulated deficit	(299,222)	(290,432)
Total shareholders' equity	707,802	679,123
Total liabilities and shareholders' equity	$ 997,080	$ 972,556

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - ₪ / shares	Mar. 31, 2024	Dec. 31, 2023
Preferred stock par value	₪ 0.01	₪ 0.01
Preferred stock authorized	50,000,000	50,000,000
Preferred stock issued	0	0
Preferred stock Outstanding	0	0
Common stock par value	₪ 0.01	₪ 0.01
Common stock Authorized	500,000,000	500,000,000
Common stock issued	108,338,295	106,114,892
Common stock Outstanding	108,338,295	106,114,892

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenue:
Total subscription revenue	$ 100,311	$ 79,820
Cost of revenue:
Total cost of revenue—subscription	20,604	18,421
Gross profit	79,707	61,399
Operating expenses:
Research and development	35,832	34,886
Sales and marketing	43,571	35,486
General and administrative	16,940	14,240
Total operating expenses	96,343	84,612
Operating loss	(16,636)	(23,213)
Interest and other income, net	7,087	3,992
Loss before income taxes	(9,549)	(19,221)
Income tax expense (benefit)	(759)	1,588
Net loss	$ (8,790)	$ (20,809)
Net loss per share, basic	$ (0.08)	$ (0.21)
Net loss per share, diluted	$ (0.08)	$ (0.21)
Weighted-average shares used in computing net loss per share, basic	107,025,351	101,260,549
Weighted-average shares used in computing net loss per share, diluted	107,025,351	101,260,549
Subscription—self-managed and SaaS
Revenue:
Total subscription revenue	$ 95,406	$ 74,543
Cost of revenue:
Total cost of revenue—subscription	20,459	18,203
License—self-managed
Revenue:
Total subscription revenue	4,905	5,277
Cost of revenue:
Total cost of revenue—subscription	$ 145	$ 218

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Statement of Comprehensive Income [Abstract]
Net Income (Loss)	$ (8,790)	$ (20,809)
Other comprehensive income (loss), net of tax:
Net change in unrealized gains (losses) on available-for-sale marketable securities, net of tax	(431)	572
Net change in unrealized losses on derivative instruments, net of tax	(726)	(173)
Other comprehensive income (loss), net of tax	(1,157)	399
Comprehensive loss	$ (9,947)	$ (20,410)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Ordinary Shares	Additional Paid-in Capital	Accumulated Other Comprehensive Income (loss)	Accumulated Deficit
Balance (in shares) at Dec. 31, 2022		100,907,857
Balance at Dec. 31, 2022	$ 624,773	$ 283	$ 856,438	$ (2,772)	$ (229,176)
Issuance of ordinary shares upon exercise of share options (in shares)		351,794
Issuance of ordinary shares upon exercise of share options	1,156	$ 1	1,155
Issuance of ordinary shares upon release of restricted share units (in shares)		371,504
Issuance of ordinary shares upon release of restricted share units		$ 1	(1)
Issuance of ordinary shares under the employee share purchase plan (shares)		207,388
Issuance of ordinary shares under the employee share purchase plan	3,499	$ 1	3,498
Share-based compensation expense	19,912		19,912
Other comprehensive income (loss), net of tax	399			399
Net Income (Loss)	(20,809)				(20,809)
Balance (in shares) at Mar. 31, 2023		101,838,543
Balance at Mar. 31, 2023	628,930	$ 286	881,002	(2,373)	(249,985)
Balance (in shares) at Dec. 31, 2023		106,114,892
Balance at Dec. 31, 2023	$ 679,123	$ 297	968,245	1,013	(290,432)
Issuance of ordinary shares upon exercise of share options (in shares)	1,280,624	1,280,624
Issuance of ordinary shares upon exercise of share options	$ 6,846	$ 4	6,842
Issuance of ordinary shares upon release of restricted share units (in shares)		764,873
Issuance of ordinary shares upon release of restricted share units		$ 2	(2)
Issuance of ordinary shares under the employee share purchase plan (shares)		177,906
Issuance of ordinary shares under the employee share purchase plan	4,494		4,494
Share-based compensation expense	27,286		27,286
Other comprehensive income (loss), net of tax	(1,157)			(1,157)
Net Income (Loss)	(8,790)				(8,790)
Balance (in shares) at Mar. 31, 2024		108,338,295
Balance at Mar. 31, 2024	$ 707,802	$ 303	$ 1,006,865	$ (144)	$ (299,222)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net Income (Loss)	$ (8,790)	$ (20,809)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	3,799	3,847
Share-based compensation expense	27,286	19,912
Non-cash operating lease expense	2,104	2,022
Net amortization of premium or discount on investments	(2,008)	(1,288)
Losses (gains) on foreign exchange	253	(367)
Changes in operating assets and liabilities:
Accounts receivable	9,781	(838)
Prepaid expenses and other assets	(4,032)	(3,114)
Deferred contract acquisition costs	(186)	(793)
Accounts payable	(2,516)	(1,086)
Accrued expenses and other liabilities	(3,213)	410
Operating lease liabilities	(2,116)	(1,737)
Deferred revenue	(2,893)	2,712
Net cash provided by (used in) operating activities	17,469	(1,129)
Cash flows from investing activities:
Purchases of short-term investments	(164,703)	(123,216)
Maturities and sales of short-term investments	118,623	114,326
Purchases of property and equipment	(841)	(266)
Net cash used in investing activities	(46,921)	(9,156)
Cash flows from financing activities:
Proceeds from exercise of share options	6,846	1,156
Proceeds from employee share purchase plan	4,494	3,499
Proceeds from employee equity transactions, net of payments to tax authorities	5,255	297
Net cash provided by financing activities	16,595	4,952
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(523)	84
Net decrease in cash, cash equivalents, and restricted cash	(13,380)	(5,249)
Cash, cash equivalents, and restricted cash—beginning of period	84,777	45,607
Cash, cash equivalents, and restricted cash—end of period	$ 71,397	$ 40,358

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Cash Flows (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2024	Mar. 31, 2023
Reconciliation of cash, cash equivalents, and restricted cash within the Condensed Consolidated Balance Sheets to the amounts shown in the Condensed Consolidated Statements of Cash Flows above:
Cash and cash equivalents	$ 71,385	$ 40,346
Restricted cash included in prepaid expenses and other current assets	12	12
Total cash, cash equivalents, and restricted cash	$ 71,397	$ 40,358

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ (8,790)	$ (20,809)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Mar. 31, 2024 shares
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	Securities Trading Plans of Directors and Executive Officers During the three months ended March 31, 2024, the following director and officers, as defined in Rule 16a-1(f) of the Exchange Act, adopted a “Rule 10b5-1 trading arrangement” as defined in Item 408 of Regulation S-K, as follows: On February 28, 2024 , Mr. Shlomi Ben Haim , our Chief Executive Officer and member of our board of directors , adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 707,155 ordinary shares. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c) of the Exchange Act. The trading arrangement terminates on the earlier of the date all transactions are completed under the trading arrangement or May 29, 2025 . On March 7, 2024 , Ms. Tali Notman , our Chief Revenue Officer , adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 293,532 ordinary shares. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c) of the Exchange Act. The trading arrangement terminates on the earlier of the date all transactions are completed under the trading arrangement or March 11, 2025 . No other officers or directors, as defined in Rule 16a-1(f), adopted or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as defined in Item 408 of Regulation S-K, during the three months ended March 31, 2024 .
Non-Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Terminated	false
Mr. Shlomi Ben Haim [Member]
Trading Arrangements, by Individual
Name	Mr. Shlomi Ben Haim
Title	Chief Executive Officer and member of our board of directors
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	February 28, 2024
Termination Date	May 29, 2025
Arrangement Duration	456 days
Aggregate Available	707,155
Mrs. Tali Notman [Member]
Trading Arrangements, by Individual
Name	Ms. Tali Notman
Title	Chief Revenue Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	March 7, 2024
Termination Date	March 11, 2025
Arrangement Duration	369 days
Aggregate Available	293,532

Organization and Description of

Organization and Description of Business	3 Months Ended
	Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	1. Organization an d Description of Business JFrog Ltd. (together with its subsi diaries, “JFrog”, or the “Company”) was incorporated under the laws of the State of Israel in 2008. JFrog provides an end-to-end, hybrid, universal Software Supply Chain Platform that enables organizations to continuously and securely create and deliver software updates across any system. This platform is the critical bridge between software development and deployment of that software, paving the way for modern software supply chain management and software release processes. The Company enables organizations to build and release software faster and more securely while empowering developers, security teams and machine learning operations teams to be more efficient. The Company’s solutions are designed to run on-premise, in public or private clouds, or in hybrid environments.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”), and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting, and include the accounts of JFrog Ltd. and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. The condensed consolidated balance sheet as of December 31, 2023 was derived from the audited consolidated financial statements as of that date, but does not include all of the disclosures, including certain notes required by GAAP on an annual reporting basis. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the related notes thereto as of and for the year ended December 31, 2023, included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 filed with the SEC on February 15, 2024. In management’s opinion, the unaudited condensed consolidated financial statements have been prepared on the same basis as the annual consolidated financial statements and reflect all adjustments, which include only normal recurring adjustments necessary for the fair presentation of the Company’s financial position as of March 31, 2024 and the Company’s consolidated results of operations, shareholders’ equity, and cash flows for the three months ended March 31, 2024 and 2023. The results for the three months ended March 31, 2024 are not necessarily indicative of the results to be expected for the full year ending December 31, 2024 or any other future interim or annual period. Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods and accompanying notes. Significant items subject to such estimates and assumptions include, but are not limited to, the allocation of transaction price among various performance obligations, the estimated benefit period of deferred contract acquisition costs, the allowance for credit losses, the fair value of acquired intangible assets and goodwill, the useful lives of acquired intangible assets and property and equipment, the incremental borrowing rate for operating leases, and the valuation of deferred tax assets and uncertain tax positions. The Company bases these estimates on historical and anticipated results, trends and various other assumptions that it believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ from those estimates. Significant Accounting Policies The Company’s significant accounting policies are discussed in Note 2, Summary of Significant Accounting Policies, in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. There have been no significant changes to these policies during the three months ended March 31, 2024 . Interest and Other Income, Net Interest and other income, net primarily consists of income earned on cash equivalents and short-term investments and foreign exchange gains and losses. Interest income was $ 7.1 million and $ 4.4 million for the three months ended March 31, 2024 and 2023 , respectively. Foreign exchange gains (losses) were not material for the periods presented. Geographical Information Revenue by geographical region can be found in Note 3, Revenue Recognition . The following table presents the Company’s long-lived assets by geographic region, which consist of property and equipment, net and operating lease right-of-use assets: March 31, 2024 December 31, 2023 (in thousands) United States $ 7,856 $ 8,566 Israel 14,768 15,888 India 3,701 4,054 Rest of world 471 582 Total long-lived assets $ 26,796 $ 29,090 Recently Issued Accounting Pronouncements In November 2023, the Financial Accounting Standard Board (“FASB”) issued ASU 2023-07, Segment Reporting (Topic 280), Improvements to Reportable Segment Disclosures , which expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses. In addition, it provides new segment disclosure requirements for entities with a single reportable segment. The guidance will be effective for the Company for annual periods beginning January 1, 2024 and for interim periods beginning January 1, 2025. Early adoption is permitted. The Company is currently evaluating the impact on its financial statement disclosures. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740), Improvements to Income Tax Disclosures , which requires disaggregated information about the effective tax rate reconciliation as well as information on income taxes paid. The guidance will be effective for the Company for annual periods beginning January 1, 2025, with e arly adoption permitted. The Company is currently evaluating the impact on its financial statement disclosures.

Revenue Recognition

Revenue Recognition	3 Months Ended
	Mar. 31, 2024
Revenue from Contract with Customer [Abstract]
Revenue Recognition	3. Revenue Recognition Disaggregation of Revenue The following table presents revenue by category: Three Months Ended March 31, 2024 2023 Amount Percentage of Revenue Amount Percentage of Revenue (in thousands, except percentages) Self-managed subscription $ 63,390 63 % $ 54,780 69 % Subscription 58,485 58 49,503 62 License 4,905 5 5,277 7 SaaS 36,921 37 25,040 31 Total subscription revenue $ 100,311 100 % $ 79,820 100 % The following table summarizes revenue by region based on the shipping address of customers: Three Months Ended March 31, 2024 2023 Amount Percentage of Revenue Amount Percentage of Revenue (in thousands, except percentages) United States $ 60,658 60 % $ 49,539 62 % Israel 2,933 3 2,043 3 Rest of world 36,720 37 28,238 35 Total subscription revenue $ 100,311 100 % $ 79,820 100 % Contract Balances Of the $ 214.1 million and $ 175.7 million of deferred revenue recorded as of December 31, 2023 and 2022 , respectively, the Company recognized $ 83.7 million and $ 63.5 million as revenue during the three months ended March 31, 2024 and 2023, respectively. Remaining Performance Obligation The Company’s remaining performance obligations are comprised of product and service revenue not yet delivered. As of March 31, 2024 , the aggregate amount of the transaction price allocated to remaining performance obligations was $ 261.7 million, which consists of billed considerations of $ 211.2 million and unbilled considerations of $ 50.5 million, that the Company expects to recognize as revenue. As of March 31, 2024 , the Company expects to recognize 82 % of its remaining performance obligations as revenue over the next 12 months, and the remainder thereafter. Cost to Obtain a Contract Amortization of deferred contract acquisition costs was $ 3.1 million and $ 2.2 million for the three months ended March 31, 2024 and 2023 , respectively.

Short-Term Investments

Short-Term Investments	3 Months Ended
	Mar. 31, 2024
Investments, All Other Investments [Abstract]
Short-Term Investments	4. Short-Term Investments Short-term investments consist of bank deposits and marketable securities. As of March 31, 2024 and December 31, 2023 , bank deposits were $ 106.7 million and $ 81.1 million, respectively. Marketable securities consist of the following: March 31, 2024 Amortized Gross Gross Estimated (in thousands) Certificates of deposit $ 2,467 $ — $ ( 11 ) $ 2,456 Commercial paper 4,147 — ( 3 ) 4,144 Corporate debt securities 161,396 95 ( 261 ) 161,230 Municipal securities 17,722 1 ( 49 ) 17,674 Government and agency debt 216,403 57 ( 429 ) 216,031 Total marketable securities 402,135 153 ( 753 ) 401,535 December 31, 2023 Amortized Gross Gross Estimated (in thousands) Certificates of deposit $ 2,455 $ — $ ( 21 ) $ 2,434 Commercial paper 8,927 — ( 6 ) 8,921 Corporate debt securities 162,515 234 ( 302 ) 162,447 Municipal securities 22,263 9 ( 36 ) 22,236 Government and agency debt 183,093 252 ( 250 ) 183,095 Total marketable securities $ 379,253 $ 495 $ ( 615 ) $ 379,133 The following table summarizes the Company’s marketable securities by contractual maturities: March 31, 2024 (in thousands) Due in 1 year or less $ 254,895 Due in 1 year through 2 years 146,640 Total $ 401,535 The following tables present fair value and gross unrealized losses of the Company’s marketable securities that have been in a continuous loss position, aggregated by length of time: March 31, 2024 Less Than 12 Months 12 Months or Greater Total Fair Value Gross Unrealized Loss Fair Value Gross Unrealized Loss Fair Value Gross Unrealized Loss (in thousands) Certificates of deposit $ 250 $ ( 1 ) $ 2,206 $ ( 10 ) $ 2,456 $ ( 11 ) Commercial paper 4,144 ( 3 ) — — 4,144 ( 3 ) Corporate debt securities 102,475 ( 218 ) 14,347 ( 43 ) 116,822 ( 261 ) Municipal securities 11,814 ( 30 ) 4,576 ( 19 ) 16,390 ( 49 ) Government and agency debt 147,125 ( 366 ) 18,669 ( 63 ) 165,794 ( 429 ) Total $ 265,808 $ ( 618 ) $ 39,798 $ ( 135 ) $ 305,606 $ ( 753 ) December 31, 2023 Less Than 12 Months 12 Months or Greater Total Fair Value Gross Unrealized Loss Fair Value Gross Unrealized Loss Fair Value Gross Unrealized Loss (in thousands) Certificates of deposit $ 250 $ — $ 2,175 $ ( 21 ) $ 2,425 $ ( 21 ) Commercial paper 8,921 ( 6 ) — — 8,921 ( 6 ) Corporate debt securities 77,023 ( 177 ) 25,156 ( 125 ) 102,179 ( 302 ) Municipal securities 7,071 ( 6 ) 4,215 ( 30 ) 11,286 ( 36 ) Government and agency debt 99,236 ( 181 ) 8,972 ( 69 ) 108,208 ( 250 ) Total $ 192,501 $ ( 370 ) $ 40,518 $ ( 245 ) $ 233,019 $ ( 615 ) As of March 31, 2024 and December 31, 2023 , the unrealized losses related to marketable securities were determined to be not due to credit related losses. Therefore, the Company did no t recognize an allowance for credit losses. See Note 12, Accumulated Other Comprehensive Income (Loss) , for the realized gains or losses from available-for-sale marketable securities that were reclassified out of accumulated other comprehensive income (loss) (“AOCI”) du ring the periods presented.

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	5. Fair Value Measurements The following tables present information about the Company’s financial instruments that are measured at fair value on a recurring basis: March 31, 2024 Fair Value Level 1 Level 2 (in thousands) Financial Assets: Money market funds $ 32,037 $ 32,037 $ — Cash equivalents 32,037 32,037 — Certificates of deposit 2,456 — 2,456 Commercial paper 4,144 — 4,144 Corporate debt securities 161,230 — 161,230 Municipal securities 17,674 — 17,674 Government and agency debt 216,031 — 216,031 Marketable securities 401,535 — 401,535 Foreign currency contracts designated as hedging instruments included in prepaid expenses and other current assets 666 — 666 Foreign currency contracts not designated as hedging instruments included in prepaid expenses and other current assets 35 — 35 Restricted bank deposits included in prepaid expenses and other current assets 12 — 12 Total financial assets $ 434,285 $ 32,037 $ 402,248 Financial Liabilities: Foreign currency contracts designated as hedging instruments included in accrued expenses and other current liabilities $ 255 $ — $ 255 Foreign currency contracts not designated as hedging instruments included in accrued expenses and other current liabilities 447 — 447 Total financial liabilities $ 702 $ — $ 702 December 31, 2023 Fair Value Level 1 Level 2 (in thousands) Financial Assets: Money market funds $ 40,646 $ 40,646 $ — Government and agency debt 5,498 — 5,498 Cash equivalents 46,144 40,646 5,498 Certificates of deposit 2,434 — 2,434 Commercial paper 8,921 — 8,921 Corporate debt securities 162,447 — 162,447 Municipal securities 22,236 — 22,236 Government and agency debt 183,095 — 183,095 Marketable securities 379,133 — 379,133 Foreign currency contracts designated as hedging instruments included in prepaid expenses and other current assets 1,189 — 1,189 Foreign currency contracts not designated as hedging instruments included in prepaid expenses and other current assets 235 — 235 Restricted bank deposits included in prepaid expenses and other current assets 12 — 12 Total financial assets $ 426,713 $ 40,646 $ 386,067 Financial Liabilities: Foreign currency contracts designated as hedging instruments included in accrued expenses and other current liabilities $ 52 $ — $ 52 Foreign currency contracts not designated as hedging instruments included in accrued expenses and other current liabilities 5 — 5 Total financial liabilities $ 57 $ — $ 57 The Company classifies its money market fund within Level 1 of the fair value hierarchy because they are valued based on quoted market prices in active markets. The Company classifies its restricted cash, certificates of deposit, commercial paper, corporate debt securities, municipal securities, government and agency debt, and derivative financial instruments within Level 2 because they are valued using inputs other than quoted prices which are directly or indirectly observable in the market, including readily-available pricing sources for the identical underlying security which may not be actively traded. As of March 31, 2024 and December 31, 2023 , the Company did no t have any assets or liabilities valued based on Level 3 valuations.

Derivative Financial Instrument

Derivative Financial Instruments and Hedging	3 Months Ended
	Mar. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments and Hedging	6. Derivative Financial Instruments and Hedging The Company enters into foreign currency forward and option contracts with financial institutions to protect against foreign exchange risks, mainly the exposure to changes in the exchange rate of the New Israeli Shekel (“NIS”) against the U.S. dollar that are associated with forecasted future cash flows and certain existing assets and liabilities for up to twelve months. The Company’s primary objective in entering into these contracts is to reduce the volatility of earnings and cash flows associated with changes in foreign currency exchange rates. The Company does not use derivative instruments for trading or speculative purposes. Notional Amount of Foreign Currency Contracts The notional amounts of outstanding foreign currency contracts in U.S. dollar as of the periods presented were as follows: March 31, 2024 December 31, 2023 (in thousands) Derivatives Designated as Hedging Instruments: Foreign currency contracts $ 57,022 $ 46,331 Derivatives Not Designated as Hedging Instruments: Foreign currency contracts 19,520 18,903 Total derivative instruments $ 76,542 $ 65,234 Effect of Foreign Currency Contracts on the Condensed Consolidated Statements of Operations Derivative instruments that hedge the exposure to variability in expected future cash flows are designated as cash flow hedges. The Company records changes in the fair value of these derivatives in AOCI in the Condensed Consolidated Balance Sheets, until the forecasted transaction occurs. Upon occurrence, the Company reclassifies the related gains or losses on the derivative to the same financial statement line item in the Condensed Consolidated Statements of Operations to which the derivative relates. In case the Company discontinues cash flow hedges, it records the related amount in interest and other income, net, on the Condensed Consolidated Statements of Operations. Derivative instruments that hedge the exposure to variability in the fair value of assets or liabilities are currently not designated as hedges for financial reporting purposes. The Company records changes in the fair value of these derivatives in interest and other income, net in the Condensed Consolidated Statements of Operations. The gains (losses) on foreign currency contracts were presented on the Condensed Consolidated Statements of Operations as follows: Derivatives Designated Derivatives Not Designated Three Months Ended March 31, Three Months Ended March 31, 2024 2023 2024 2023 Condensed Statement of Operations Location: (in thousands) Cost of revenue: subscription–self-managed and SaaS $ 20 $ ( 87 ) $ — $ — Research and development 187 ( 688 ) — — Sales and marketing 46 ( 152 ) — — General and administrative 51 ( 181 ) — — Interest and other income, net — — ( 223 ) ( 405 ) Total gains (losses) recognized in earnings $ 304 $ ( 1,108 ) $ ( 223 ) $ ( 405 ) Effect of Foreign Currency Contracts on Accumulated Other Comprehensive Income Net unrealized gains (losses) of foreign currency contracts designated as hedging instruments, net of tax, are recorded in AOCI. See Note 12, Accumulated Other Comprehensive Income (Loss) , for the effect on other comprehensive income (loss) and the reclassification out of AOCI during the periods presented. All of net deferred losses in AOCI as of March 31, 2024 are expected to be recognized as operating expenses in the same financial statement line item in the Condensed Consolidated Statements of Operations to which the derivative relates over the next twelve months.

Condensed Consolidated Balanc_3

Condensed Consolidated Balance Sheet Components	3 Months Ended
	Mar. 31, 2024
Balance Sheet Related Disclosures [Abstract]
Condensed Consolidated Balance Sheet Components	7. Condensed Consolidated Balance Sheet Components Property and Equipment, Net Property and equipment, net consisted of the following: March 31, 2024 December 31, 2023 (in thousands) Computer and software $ 9,655 $ 9,030 Furniture and office equipment 3,188 3,135 Leasehold improvements 6,112 6,069 Property and equipment, gross 18,955 18,234 Less: accumulated depreciation and amortization ( 12,482 ) ( 11,571 ) Property and equipment, net $ 6,473 $ 6,663 Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following: March 31, 2024 December 31, 2023 (in thousands) Accrued compensation and benefits $ 22,724 $ 25,166 Accrued expenses 16,873 10,649 Accrued expenses and other current liabilities $ 39,597 $ 35,815

Intangible Assets, Net

Intangible Assets, Net	3 Months Ended
	Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets, Net	8. Intangible Assets, Net Intangible assets consisted of the following as of March 31, 2024: Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted-Average (in thousands) (in years) Developed technology $ 50,347 $ ( 30,310 ) $ 20,037 2.1 Customer relationships 5,541 ( 3,023 ) 2,518 2.9 Other intangible assets 1,132 ( 808 ) 324 0.7 Total $ 57,020 $ ( 34,141 ) $ 22,879 Intangible assets consisted of the following as of December 31, 2023: Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted-Average (in thousands) (in years) Developed technology $ 50,347 $ ( 27,779 ) $ 22,568 2.3 Customer relationships 5,541 ( 2,786 ) 2,755 3.1 Other intangible assets 1,132 ( 687 ) 445 0.9 Total $ 57,020 $ ( 31,252 ) $ 25,768 Amortization expenses for intangible assets were $ 2.9 million and $ 3.0 million for the three months ended March 31, 2024 and 2023, respectively. The expected future amortization expenses by year related to the intangible assets as of March 31, 2024 are as follows: March 31, 2024 (in thousands) Year Ending December 31, 2024 (Remainder) $ 8,145 2025 9,110 2026 5,241 2027 383 Total $ 22,879

Leases

Leases	3 Months Ended
	Mar. 31, 2024
Leases [Abstract]
Leases	9. Leases The Company has entered into non-cancelable lease agreements for its offices with lease periods expiring at various dates through March 2028. Components of operating lease expense were as follows: Three Months Ended March 31, 2024 2023 (in thousands) Operating lease cost $ 2,275 $ 2,181 Short-term lease cost 176 112 Variable lease cost 103 96 Total operating lease cost $ 2,554 $ 2,389 Supplementary cash flow information related to operating leases was as follows: Three Months Ended March 31, 2024 2023 (in thousands) Cash paid for operating leases $ 2,288 $ 1,896 ROU assets obtained in exchange for new operating lease liabilities $ — $ 2,867 As of March 31, 2024 , the weighted-average discount rate is 2.7 % and the weighted-average remaining term is 3.4 years. Maturities of the Company’s operating lease liabilities as of March 31, 2024 were as follows: March 31, 2024 (in thousands) Year Ending December 31, 2024 (Remainder) $ 6,518 2025 7,884 2026 4,649 2027 1,616 2028 156 Total operating lease payments 20,823 Less: imputed interest ( 983 ) Total operating lease liabilities $ 19,840

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	10. Commitments and Contingencies Non-cancelable Purchase Obligations In the normal course of business, the Company enters into non-cancelable purchase commitments with various parties mainly for hosting services, as well as software products and services. As of March 31, 2024, the Company had outstanding non-cancelable purchase obligations with a term of 12 months or longer as follows: March 31, 2024 (in thousands) Year Ending December 31, 2024 (Remainder) $ 4,996 2025 16,980 2026 2,600 2027 25 2028 25 Total $ 24,626 Indemnifications and Contingencies The Company enters into indemnification provisions under certain agreements with other parties in the ordinary course of business. In its customer agreements, the Company has agreed to indemnify, defend and hold harmless the indemnified party for third party claims and related losses suffered or incurred by the indemnified party from actual or threatened third-party intellectual property infringement claims. For certain large or strategic customers, the Company has agreed to indemnify, defend and hold harmless the indemnified party for certain additional matters including but not limited to non-compliance with certain representations and warranties made by the Company. Grants from Israeli Innovation Authority The Company has received in the past grants from the Israeli Innovation Authority (“IIA”) and repaid them in full. Still, as any grant recipient, the Company is subject to the provisions of the Israeli Law for the Encouragement of Research, Development and Technological Innovation in the Industry and the regulations and guidelines thereunder (the “Innovation Law”). Pursuant to the Innovation Law, there are restrictions related to transferring intellectual property outside of Israel. Such transfer requires the approval from the IIA. The approval may be subject to a maximum additional payment amount of approximately $ 6.0 million. In the past, the Company received an approval from the IIA to perform a limited development of IIA funded know-how outside of Israel, subject to the terms specified in the IIA approval, including that all of its core R&D activities will remain in Israel. Legal Proceedings In the ordinary course of business, the Company may be subject from time to time to various proceedings, lawsuits, disputes, or claims. The Company investigates these claims as they arise. Although claims are inherently unpredictable, the Company is currently not aware of any matters that, if determined adversely to the Company, would individually or taken together, have a material adverse effect on its business, financial position, results of operations, or cash flows.

Shareholders' Equity and Equity

Shareholders' Equity and Equity Incentive Plans	3 Months Ended
	Mar. 31, 2024
Equity [Abstract]
Shareholders' Equity and Equity Incentive Plans	11. Shareholders’ Equity and Equity Incentive Plans Equity Incentive Plans Effective January 1, 2024 , the number of ordinary shares authorized for issuance under the 2020 Equity Incentive Plan (the “2020 Plan”) automatically increased by 6,070,667 shares pursuant to the terms of the 2020 Plan. Share Options A summary of share option activity under the Company’s equity incentive plans and related information is as follows: Options Outstanding Outstanding Weighted-Average Exercise Weighted-Average Remaining Aggregate (in thousands, except share, life and per share data) Balance as of December 31, 2023 5,110,390 $ 8.49 4.1 $ 134,171 Exercised ( 1,280,624 ) $ 5.27 $ 46,905 Forfeited ( 9,900 ) $ 12.61 Balance as of March 31, 2024 3,819,866 $ 9.57 4.5 $ 132,808 Exercisable as of March 31, 2024 3,294,042 $ 8.11 4.3 $ 119,216 Restricted Share Units A summary of restricted share units (“RSU”) activity under the Company’s equity incentive plan and related information is as follows, including performance-based RSUs with a market condition: RSUs Unvested RSUs Weighted-Average Unvested as of December 31, 2023 10,006,997 $ 25.91 Granted 777,826 $ 35.67 Vested ( 764,873 ) $ 25.52 Forfeited ( 239,450 ) $ 25.37 Unvested as of March 31, 2024 9,780,500 $ 26.75 The total release date fair value of RSUs was $ 34.1 million during the three months ended March 31, 2024. Employee Share Purchase Plan Effective January 1, 2024 , the number of ordinary shares authorized for issuance under the 2020 Employee Share Purchase Plan (“ESPP”) automatically increased by 1,061,148 shares pursuant to the terms of ESPP. Shares Reserved for Future Issuance The Company has the following ordinary shares reserved for future issuance: March 31, 2024 Outstanding share options 3,819,866 Outstanding RSUs 9,780,500 Shares available for future issuance under the 2020 Plan 19,757,175 Shares available for future issuance under ESPP 5,164,907 Total ordinary shares reserved 38,522,448 Share-Based Compensation The share-based compensation expense by line item in the accompanying Condensed Consolidated Statements of Operations is summarized as follows: Three Months Ended March 31, 2024 2023 (in thousands) Cost of revenue: subscription–self-managed and SaaS $ 3,092 $ 2,196 Research and development 9,667 7,172 Sales and marketing 9,813 6,473 General and administrative 4,714 4,071 Total share-based compensation expense $ 27,286 $ 19,912 As of March 31, 2024 , unrecognized share-based compensation cost related to unvested share-based compensation awards was $ 237.5 million, which is expected to be recognized over a weighted-average period of 2.7 years.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income (Loss)	3 Months Ended
	Mar. 31, 2024
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated Other Comprehensive Income (Loss)	12. Accumulated Other Comprehensive Income (Loss) The following table summarizes the changes in AOCI by component, net of tax, during the periods presented: Net Unrealized Net Unrealized Total (in thousands) Balance as of December 31, 2023 $ ( 124 ) $ 1,137 $ 1,013 Other comprehensive loss before reclassifications ( 428 ) ( 422 ) ( 850 ) Net realized gains reclassified from AOCI ( 3 ) ( 304 ) ( 307 ) Other comprehensive loss ( 431 ) ( 726 ) ( 1,157 ) Balance as of March 31, 2024 $ ( 555 ) $ 411 $ ( 144 ) Net Unrealized Net Unrealized Total (in thousands) Balance as of December 31, 2022 $ ( 1,694 ) $ ( 1,078 ) $ ( 2,772 ) Other comprehensive income (loss) before reclassifications 411 ( 1,281 ) ( 870 ) Net realized losses reclassified from AOCI 161 1,108 1,269 Other comprehensive income (loss) 572 ( 173 ) 399 Balance as of March 31, 2023 $ ( 1,122 ) $ ( 1,251 ) $ ( 2,373 )

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	13. Income Taxes The Company’s quarterly tax provision and estimates of its annual effective tax rate are subject to variation due to several factors, including variability in pre-tax income (or loss), the mix of jurisdictions to which such income relates, tax law developments, as well as non-deductible expenses, such as share-based compensation, and changes in its valuation allowance. Income tax expense (benefit) was $ ( 0.8 ) million and $ 1.6 million for the three months ended March 31, 2024 and 2023, respectively. The income tax expense (benefit) for the periods consisted primarily of income taxes related to the Company’s operations in the United States. A valuation allowance is provided when it is more likely than not that the deferred tax assets will not be realized. Based on the available objective evidence during three months ended March 31, 2024, the Company believes it is more likely than not that the tax benefits of the Company’s losses incurred in Israel may not be realized. Gross unrecognized tax benefits were $ 5.4 million as of March 31, 2024 and December 31, 2023. As of March 31, 2024 , the Company does not expect its unrecognized tax benefits to change significantly within the next twelve months.

Net Loss Per Share

Net Loss Per Share	3 Months Ended
	Mar. 31, 2024
Earnings Per Share [Abstract]
Net Loss Per Share	14. Net Loss Per Share The following table sets forth the computation of basic and diluted net loss per share for the periods presented: Three Months Ended March 31, 2024 2023 (in thousands, except share and per share data) Numerator: Net loss $ ( 8,790 ) $ ( 20,809 ) Denominator: Weighted-average shares used in computing net loss per share, basic and diluted 107,025,351 101,260,549 Net loss per share, basic and diluted $ ( 0.08 ) $ ( 0.21 ) The potential shares of ordinary shares that were excluded from the computation of diluted net loss per share for the periods presented because including them would have been anti-dilutive are as follows: Three Months Ended March 31, 2024 2023 Outstanding share options 4,543,485 7,025,265 Unvested RSUs 10,073,530 8,052,284 Share purchase rights under the ESPP 160,553 197,335 Issuable ordinary shares related to business combination — 55,466 Total 14,777,568 15,330,350

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”), and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting, and include the accounts of JFrog Ltd. and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. The condensed consolidated balance sheet as of December 31, 2023 was derived from the audited consolidated financial statements as of that date, but does not include all of the disclosures, including certain notes required by GAAP on an annual reporting basis. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the related notes thereto as of and for the year ended December 31, 2023, included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 filed with the SEC on February 15, 2024. In management’s opinion, the unaudited condensed consolidated financial statements have been prepared on the same basis as the annual consolidated financial statements and reflect all adjustments, which include only normal recurring adjustments necessary for the fair presentation of the Company’s financial position as of March 31, 2024 and the Company’s consolidated results of operations, shareholders’ equity, and cash flows for the three months ended March 31, 2024 and 2023. The results for the three months ended March 31, 2024 are not necessarily indicative of the results to be expected for the full year ending December 31, 2024 or any other future interim or annual period.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods and accompanying notes. Significant items subject to such estimates and assumptions include, but are not limited to, the allocation of transaction price among various performance obligations, the estimated benefit period of deferred contract acquisition costs, the allowance for credit losses, the fair value of acquired intangible assets and goodwill, the useful lives of acquired intangible assets and property and equipment, the incremental borrowing rate for operating leases, and the valuation of deferred tax assets and uncertain tax positions. The Company bases these estimates on historical and anticipated results, trends and various other assumptions that it believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ from those estimates.
Significant Accounting Policies	Significant Accounting Policies The Company’s significant accounting policies are discussed in Note 2, Summary of Significant Accounting Policies, in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. There have been no significant changes to these policies during the three months ended March 31, 2024 .
Fair Value Measurements	The Company classifies its money market fund within Level 1 of the fair value hierarchy because they are valued based on quoted market prices in active markets. The Company classifies its restricted cash, certificates of deposit, commercial paper, corporate debt securities, municipal securities, government and agency debt, and derivative financial instruments within Level 2 because they are valued using inputs other than quoted prices which are directly or indirectly observable in the market, including readily-available pricing sources for the identical underlying security which may not be actively traded. As of March 31, 2024 and December 31, 2023 , the Company did no t have any assets or liabilities valued based on Level 3 valuations.
Effect of Foreign Currency Contracts on the Condensed Consolidated Statements of Operations	Effect of Foreign Currency Contracts on the Condensed Consolidated Statements of Operations Derivative instruments that hedge the exposure to variability in expected future cash flows are designated as cash flow hedges. The Company records changes in the fair value of these derivatives in AOCI in the Condensed Consolidated Balance Sheets, until the forecasted transaction occurs. Upon occurrence, the Company reclassifies the related gains or losses on the derivative to the same financial statement line item in the Condensed Consolidated Statements of Operations to which the derivative relates. In case the Company discontinues cash flow hedges, it records the related amount in interest and other income, net, on the Condensed Consolidated Statements of Operations. Derivative instruments that hedge the exposure to variability in the fair value of assets or liabilities are currently not designated as hedges for financial reporting purposes. The Company records changes in the fair value of these derivatives in interest and other income, net in the Condensed Consolidated Statements of Operations.
Interest and Other Income, Net	Interest and Other Income, Net Interest and other income, net primarily consists of income earned on cash equivalents and short-term investments and foreign exchange gains and losses. Interest income was $ 7.1 million and $ 4.4 million for the three months ended March 31, 2024 and 2023 , respectively. Foreign exchange gains (losses) were not material for the periods presented.
Geographical Information	Geographical Information Revenue by geographical region can be found in Note 3, Revenue Recognition . The following table presents the Company’s long-lived assets by geographic region, which consist of property and equipment, net and operating lease right-of-use assets: March 31, 2024 December 31, 2023 (in thousands) United States $ 7,856 $ 8,566 Israel 14,768 15,888 India 3,701 4,054 Rest of world 471 582 Total long-lived assets $ 26,796 $ 29,090
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In November 2023, the Financial Accounting Standard Board (“FASB”) issued ASU 2023-07, Segment Reporting (Topic 280), Improvements to Reportable Segment Disclosures , which expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses. In addition, it provides new segment disclosure requirements for entities with a single reportable segment. The guidance will be effective for the Company for annual periods beginning January 1, 2024 and for interim periods beginning January 1, 2025. Early adoption is permitted. The Company is currently evaluating the impact on its financial statement disclosures. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740), Improvements to Income Tax Disclosures , which requires disaggregated information about the effective tax rate reconciliation as well as information on income taxes paid. The guidance will be effective for the Company for annual periods beginning January 1, 2025, with e arly adoption permitted. The Company is currently evaluating the impact on its financial statement disclosures.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Summary of Long Lived Assets by Geographic Region	The following table presents the Company’s long-lived assets by geographic region, which consist of property and equipment, net and operating lease right-of-use assets: March 31, 2024 December 31, 2023 (in thousands) United States $ 7,856 $ 8,566 Israel 14,768 15,888 India 3,701 4,054 Rest of world 471 582 Total long-lived assets $ 26,796 $ 29,090

Revenue Recognition (Tables)

Revenue Recognition (Tables)	3 Months Ended
	Mar. 31, 2024
Revenue from Contract with Customer [Abstract]
Summary of table presents revenue as follows	The following table presents revenue by category: Three Months Ended March 31, 2024 2023 Amount Percentage of Revenue Amount Percentage of Revenue (in thousands, except percentages) Self-managed subscription $ 63,390 63 % $ 54,780 69 % Subscription 58,485 58 49,503 62 License 4,905 5 5,277 7 SaaS 36,921 37 25,040 31 Total subscription revenue $ 100,311 100 % $ 79,820 100 %
Summary of table by region based on the shipping address of customers	The following table summarizes revenue by region based on the shipping address of customers: Three Months Ended March 31, 2024 2023 Amount Percentage of Revenue Amount Percentage of Revenue (in thousands, except percentages) United States $ 60,658 60 % $ 49,539 62 % Israel 2,933 3 2,043 3 Rest of world 36,720 37 28,238 35 Total subscription revenue $ 100,311 100 % $ 79,820 100 %

Short-Term Investments (Tables)

Short-Term Investments (Tables)	3 Months Ended
	Mar. 31, 2024
Investments, All Other Investments [Abstract]
Summary of Marketable Securities	Marketable securities consist of the following: March 31, 2024 Amortized Gross Gross Estimated (in thousands) Certificates of deposit $ 2,467 $ — $ ( 11 ) $ 2,456 Commercial paper 4,147 — ( 3 ) 4,144 Corporate debt securities 161,396 95 ( 261 ) 161,230 Municipal securities 17,722 1 ( 49 ) 17,674 Government and agency debt 216,403 57 ( 429 ) 216,031 Total marketable securities 402,135 153 ( 753 ) 401,535 December 31, 2023 Amortized Gross Gross Estimated (in thousands) Certificates of deposit $ 2,455 $ — $ ( 21 ) $ 2,434 Commercial paper 8,927 — ( 6 ) 8,921 Corporate debt securities 162,515 234 ( 302 ) 162,447 Municipal securities 22,263 9 ( 36 ) 22,236 Government and agency debt 183,093 252 ( 250 ) 183,095 Total marketable securities $ 379,253 $ 495 $ ( 615 ) $ 379,133
Summary of Company's Marketable Securities by Contractual Maturities	The following table summarizes the Company’s marketable securities by contractual maturities: March 31, 2024 (in thousands) Due in 1 year or less $ 254,895 Due in 1 year through 2 years 146,640 Total $ 401,535
Summary of Presents Fair Value and Gross Unrealized Losses of the Company's Marketable Securities	The following tables present fair value and gross unrealized losses of the Company’s marketable securities that have been in a continuous loss position, aggregated by length of time: March 31, 2024 Less Than 12 Months 12 Months or Greater Total Fair Value Gross Unrealized Loss Fair Value Gross Unrealized Loss Fair Value Gross Unrealized Loss (in thousands) Certificates of deposit $ 250 $ ( 1 ) $ 2,206 $ ( 10 ) $ 2,456 $ ( 11 ) Commercial paper 4,144 ( 3 ) — — 4,144 ( 3 ) Corporate debt securities 102,475 ( 218 ) 14,347 ( 43 ) 116,822 ( 261 ) Municipal securities 11,814 ( 30 ) 4,576 ( 19 ) 16,390 ( 49 ) Government and agency debt 147,125 ( 366 ) 18,669 ( 63 ) 165,794 ( 429 ) Total $ 265,808 $ ( 618 ) $ 39,798 $ ( 135 ) $ 305,606 $ ( 753 ) December 31, 2023 Less Than 12 Months 12 Months or Greater Total Fair Value Gross Unrealized Loss Fair Value Gross Unrealized Loss Fair Value Gross Unrealized Loss (in thousands) Certificates of deposit $ 250 $ — $ 2,175 $ ( 21 ) $ 2,425 $ ( 21 ) Commercial paper 8,921 ( 6 ) — — 8,921 ( 6 ) Corporate debt securities 77,023 ( 177 ) 25,156 ( 125 ) 102,179 ( 302 ) Municipal securities 7,071 ( 6 ) 4,215 ( 30 ) 11,286 ( 36 ) Government and agency debt 99,236 ( 181 ) 8,972 ( 69 ) 108,208 ( 250 ) Total $ 192,501 $ ( 370 ) $ 40,518 $ ( 245 ) $ 233,019 $ ( 615 )

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2024
Fair Value Disclosures [Abstract]
Summary of Fair Value by Balance Sheet Grouping	The following tables present information about the Company’s financial instruments that are measured at fair value on a recurring basis: March 31, 2024 Fair Value Level 1 Level 2 (in thousands) Financial Assets: Money market funds $ 32,037 $ 32,037 $ — Cash equivalents 32,037 32,037 — Certificates of deposit 2,456 — 2,456 Commercial paper 4,144 — 4,144 Corporate debt securities 161,230 — 161,230 Municipal securities 17,674 — 17,674 Government and agency debt 216,031 — 216,031 Marketable securities 401,535 — 401,535 Foreign currency contracts designated as hedging instruments included in prepaid expenses and other current assets 666 — 666 Foreign currency contracts not designated as hedging instruments included in prepaid expenses and other current assets 35 — 35 Restricted bank deposits included in prepaid expenses and other current assets 12 — 12 Total financial assets $ 434,285 $ 32,037 $ 402,248 Financial Liabilities: Foreign currency contracts designated as hedging instruments included in accrued expenses and other current liabilities $ 255 $ — $ 255 Foreign currency contracts not designated as hedging instruments included in accrued expenses and other current liabilities 447 — 447 Total financial liabilities $ 702 $ — $ 702 December 31, 2023 Fair Value Level 1 Level 2 (in thousands) Financial Assets: Money market funds $ 40,646 $ 40,646 $ — Government and agency debt 5,498 — 5,498 Cash equivalents 46,144 40,646 5,498 Certificates of deposit 2,434 — 2,434 Commercial paper 8,921 — 8,921 Corporate debt securities 162,447 — 162,447 Municipal securities 22,236 — 22,236 Government and agency debt 183,095 — 183,095 Marketable securities 379,133 — 379,133 Foreign currency contracts designated as hedging instruments included in prepaid expenses and other current assets 1,189 — 1,189 Foreign currency contracts not designated as hedging instruments included in prepaid expenses and other current assets 235 — 235 Restricted bank deposits included in prepaid expenses and other current assets 12 — 12 Total financial assets $ 426,713 $ 40,646 $ 386,067 Financial Liabilities: Foreign currency contracts designated as hedging instruments included in accrued expenses and other current liabilities $ 52 $ — $ 52 Foreign currency contracts not designated as hedging instruments included in accrued expenses and other current liabilities 5 — 5 Total financial liabilities $ 57 $ — $ 57

Derivative Financial Instrume_2

Derivative Financial Instruments and Hedging (Tables)	3 Months Ended
	Mar. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Disclosure of Notional Amount of Derivatives by Hedging Designation	The notional amounts of outstanding foreign currency contracts in U.S. dollar as of the periods presented were as follows: March 31, 2024 December 31, 2023 (in thousands) Derivatives Designated as Hedging Instruments: Foreign currency contracts $ 57,022 $ 46,331 Derivatives Not Designated as Hedging Instruments: Foreign currency contracts 19,520 18,903 Total derivative instruments $ 76,542 $ 65,234
Derivative Instruments, Gain (Loss)	The gains (losses) on foreign currency contracts were presented on the Condensed Consolidated Statements of Operations as follows: Derivatives Designated Derivatives Not Designated Three Months Ended March 31, Three Months Ended March 31, 2024 2023 2024 2023 Condensed Statement of Operations Location: (in thousands) Cost of revenue: subscription–self-managed and SaaS $ 20 $ ( 87 ) $ — $ — Research and development 187 ( 688 ) — — Sales and marketing 46 ( 152 ) — — General and administrative 51 ( 181 ) — — Interest and other income, net — — ( 223 ) ( 405 ) Total gains (losses) recognized in earnings $ 304 $ ( 1,108 ) $ ( 223 ) $ ( 405 )

Condensed Consolidated Balanc_4

Condensed Consolidated Balance Sheet Components (Tables)	3 Months Ended
	Mar. 31, 2024
Balance Sheet Related Disclosures [Abstract]
Summary of Property and Equipment	Property and equipment, net consisted of the following: March 31, 2024 December 31, 2023 (in thousands) Computer and software $ 9,655 $ 9,030 Furniture and office equipment 3,188 3,135 Leasehold improvements 6,112 6,069 Property and equipment, gross 18,955 18,234 Less: accumulated depreciation and amortization ( 12,482 ) ( 11,571 ) Property and equipment, net $ 6,473 $ 6,663
Summary of Accrued Expenses and Other Current Liabilities	Accrued expenses and other current liabilities consisted of the following: March 31, 2024 December 31, 2023 (in thousands) Accrued compensation and benefits $ 22,724 $ 25,166 Accrued expenses 16,873 10,649 Accrued expenses and other current liabilities $ 39,597 $ 35,815

Intangible Assets, Net (Tables)

Intangible Assets, Net (Tables)	3 Months Ended
	Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Summary of intangible assets	Intangible assets consisted of the following as of March 31, 2024: Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted-Average (in thousands) (in years) Developed technology $ 50,347 $ ( 30,310 ) $ 20,037 2.1 Customer relationships 5,541 ( 3,023 ) 2,518 2.9 Other intangible assets 1,132 ( 808 ) 324 0.7 Total $ 57,020 $ ( 34,141 ) $ 22,879 Intangible assets consisted of the following as of December 31, 2023: Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted-Average (in thousands) (in years) Developed technology $ 50,347 $ ( 27,779 ) $ 22,568 2.3 Customer relationships 5,541 ( 2,786 ) 2,755 3.1 Other intangible assets 1,132 ( 687 ) 445 0.9 Total $ 57,020 $ ( 31,252 ) $ 25,768
Summary of expected future amortization expenses by year related to the intangible assets	The expected future amortization expenses by year related to the intangible assets as of March 31, 2024 are as follows: March 31, 2024 (in thousands) Year Ending December 31, 2024 (Remainder) $ 8,145 2025 9,110 2026 5,241 2027 383 Total $ 22,879

Leases (Tables)

Leases (Tables)	3 Months Ended
	Mar. 31, 2024
Leases [Abstract]
Components of Operating Lease Expense	Components of operating lease expense were as follows: Three Months Ended March 31, 2024 2023 (in thousands) Operating lease cost $ 2,275 $ 2,181 Short-term lease cost 176 112 Variable lease cost 103 96 Total operating lease cost $ 2,554 $ 2,389
Supplementary Cash Flow Information Related to Operating Leases	Supplementary cash flow information related to operating leases was as follows: Three Months Ended March 31, 2024 2023 (in thousands) Cash paid for operating leases $ 2,288 $ 1,896 ROU assets obtained in exchange for new operating lease liabilities $ — $ 2,867
Schedule of Maturities of Operating Lease Liabilities	As of March 31, 2024 , the weighted-average discount rate is 2.7 % and the weighted-average remaining term is 3.4 years. Maturities of the Company’s operating lease liabilities as of March 31, 2024 were as follows: March 31, 2024 (in thousands) Year Ending December 31, 2024 (Remainder) $ 6,518 2025 7,884 2026 4,649 2027 1,616 2028 156 Total operating lease payments 20,823 Less: imputed interest ( 983 ) Total operating lease liabilities $ 19,840

Commitments and Contingencies (

Commitments and Contingencies (Tables)	3 Months Ended
	Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Summary of outstanding non-cancelable purchase obligations	In the normal course of business, the Company enters into non-cancelable purchase commitments with various parties mainly for hosting services, as well as software products and services. As of March 31, 2024, the Company had outstanding non-cancelable purchase obligations with a term of 12 months or longer as follows: March 31, 2024 (in thousands) Year Ending December 31, 2024 (Remainder) $ 4,996 2025 16,980 2026 2,600 2027 25 2028 25 Total $ 24,626

Shareholders' Equity and Equi_2

Shareholders' Equity and Equity Incentive Plans (Tables)	3 Months Ended
	Mar. 31, 2024
Equity [Abstract]
Summary of Stock Option Activity	A summary of share option activity under the Company’s equity incentive plans and related information is as follows: Options Outstanding Outstanding Weighted-Average Exercise Weighted-Average Remaining Aggregate (in thousands, except share, life and per share data) Balance as of December 31, 2023 5,110,390 $ 8.49 4.1 $ 134,171 Exercised ( 1,280,624 ) $ 5.27 $ 46,905 Forfeited ( 9,900 ) $ 12.61 Balance as of March 31, 2024 3,819,866 $ 9.57 4.5 $ 132,808 Exercisable as of March 31, 2024 3,294,042 $ 8.11 4.3 $ 119,216
Summary of Restricted Ordinary Shares	A summary of restricted share units (“RSU”) activity under the Company’s equity incentive plan and related information is as follows, including performance-based RSUs with a market condition: RSUs Unvested RSUs Weighted-Average Unvested as of December 31, 2023 10,006,997 $ 25.91 Granted 777,826 $ 35.67 Vested ( 764,873 ) $ 25.52 Forfeited ( 239,450 ) $ 25.37 Unvested as of March 31, 2024 9,780,500 $ 26.75
Summary of Ordinary Shares Reserved for Future Issuance	The Company has the following ordinary shares reserved for future issuance: March 31, 2024 Outstanding share options 3,819,866 Outstanding RSUs 9,780,500 Shares available for future issuance under the 2020 Plan 19,757,175 Shares available for future issuance under ESPP 5,164,907 Total ordinary shares reserved 38,522,448
Summary of Stock-Based Compensation Expense	The share-based compensation expense by line item in the accompanying Condensed Consolidated Statements of Operations is summarized as follows: Three Months Ended March 31, 2024 2023 (in thousands) Cost of revenue: subscription–self-managed and SaaS $ 3,092 $ 2,196 Research and development 9,667 7,172 Sales and marketing 9,813 6,473 General and administrative 4,714 4,071 Total share-based compensation expense $ 27,286 $ 19,912

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income (Loss) (Tables)	3 Months Ended
	Mar. 31, 2024
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Summary of Changes in AOCI	The following table summarizes the changes in AOCI by component, net of tax, during the periods presented: Net Unrealized Net Unrealized Total (in thousands) Balance as of December 31, 2023 $ ( 124 ) $ 1,137 $ 1,013 Other comprehensive loss before reclassifications ( 428 ) ( 422 ) ( 850 ) Net realized gains reclassified from AOCI ( 3 ) ( 304 ) ( 307 ) Other comprehensive loss ( 431 ) ( 726 ) ( 1,157 ) Balance as of March 31, 2024 $ ( 555 ) $ 411 $ ( 144 ) Net Unrealized Net Unrealized Total (in thousands) Balance as of December 31, 2022 $ ( 1,694 ) $ ( 1,078 ) $ ( 2,772 ) Other comprehensive income (loss) before reclassifications 411 ( 1,281 ) ( 870 ) Net realized losses reclassified from AOCI 161 1,108 1,269 Other comprehensive income (loss) 572 ( 173 ) 399 Balance as of March 31, 2023 $ ( 1,122 ) $ ( 1,251 ) $ ( 2,373 )

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	3 Months Ended
	Mar. 31, 2024
Earnings Per Share [Abstract]
Summary of computation of basic and diluted net loss per share	The following table sets forth the computation of basic and diluted net loss per share for the periods presented: Three Months Ended March 31, 2024 2023 (in thousands, except share and per share data) Numerator: Net loss $ ( 8,790 ) $ ( 20,809 ) Denominator: Weighted-average shares used in computing net loss per share, basic and diluted 107,025,351 101,260,549 Net loss per share, basic and diluted $ ( 0.08 ) $ ( 0.21 )
Summary of shares excluded from the computation of diluted net loss per share	The potential shares of ordinary shares that were excluded from the computation of diluted net loss per share for the periods presented because including them would have been anti-dilutive are as follows: Three Months Ended March 31, 2024 2023 Outstanding share options 4,543,485 7,025,265 Unvested RSUs 10,073,530 8,052,284 Share purchase rights under the ESPP 160,553 197,335 Issuable ordinary shares related to business combination — 55,466 Total 14,777,568 15,330,350

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Accounting Policies [Abstract]
Interest income	$ 7.1	$ 4.4

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Summary of Long Lived Assets by Geographic Region (Detail) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Revenues from External Customers and Long-Lived Assets [Line Items]
Total long lived assets	$ 26,796	$ 29,090
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Total long lived assets	7,856	8,566
Israel
Revenues from External Customers and Long-Lived Assets [Line Items]
Total long lived assets	14,768	15,888
India
Revenues from External Customers and Long-Lived Assets [Line Items]
Total long lived assets	3,701	4,054
Rest of world
Revenues from External Customers and Long-Lived Assets [Line Items]
Total long lived assets	$ 471	$ 582

Revenue Recognition - Additiona

Revenue Recognition - Additional Information (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Dec. 31, 2022
Disaggregation of Revenue [Line Items]
Deferred Revenue			$ 214.1	$ 175.7
Contract with Customer, Liability, Revenue Recognized	$ 83.7	$ 63.5
Revenue, Remaining Performance Obligation	$ 261.7
Revenue, Remaining Performance Obligation, Percentage	82%
Amortization of deferred contract acquisition costs	$ 3.1	$ 2.2
Billed Revenues [Member]
Disaggregation of Revenue [Line Items]
Revenue, Remaining Performance Obligation	211.2
Unbilled Revenues [Member]
Disaggregation of Revenue [Line Items]
Revenue, Remaining Performance Obligation	$ 50.5

Revenue Recognition - Additio_2

Revenue Recognition - Additional Information (Detail 1)	Mar. 31, 2024
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-04-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	12 months

Revenue Recognition - Summary o

Revenue Recognition - Summary of Table Presents Revenue as Follows (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Disaggregation of Revenue [Line Items]
Total subscription revenue	$ 100,311	$ 79,820
Sale revenue [Member] | Product Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Percentage of revenue	100%	100%
Subscription
Disaggregation of Revenue [Line Items]
Total subscription revenue	$ 58,485	$ 49,503
Subscription | Sale revenue [Member] | Product Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Percentage of revenue	58%	62%
Selfmanaged Subscription [Member]
Disaggregation of Revenue [Line Items]
Total subscription revenue	$ 63,390	$ 54,780
Selfmanaged Subscription [Member] | Sale revenue [Member] | Product Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Percentage of revenue	63%	69%
License [Member]
Disaggregation of Revenue [Line Items]
Total subscription revenue	$ 4,905	$ 5,277
License [Member] | Sale revenue [Member] | Product Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Percentage of revenue	5%	7%
SaaS [Member]
Disaggregation of Revenue [Line Items]
Total subscription revenue	$ 36,921	$ 25,040
SaaS [Member] | Sale revenue [Member] | Product Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Percentage of revenue	37%	31%

Revenue Recognition - Summary_2

Revenue Recognition - Summary of Revenue by Region Based on The Shipping Address of Customers as Follows (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Disaggregation of Revenue [Line Items]
Total subscription revenue	$ 100,311	$ 79,820
Revenue Benchmark [Member] | Geographic Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Percentage of revenue	100%	100%
UNITED STATES
Disaggregation of Revenue [Line Items]
Total subscription revenue	$ 60,658	$ 49,539
UNITED STATES | Revenue Benchmark [Member] | Geographic Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Percentage of revenue	60%	62%
ISRAEL
Disaggregation of Revenue [Line Items]
Total subscription revenue	$ 2,933	$ 2,043
ISRAEL | Revenue Benchmark [Member] | Geographic Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Percentage of revenue	3%	3%
Rest of world [Member]
Disaggregation of Revenue [Line Items]
Total subscription revenue	$ 36,720	$ 28,238
Rest of world [Member] | Revenue Benchmark [Member] | Geographic Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Percentage of revenue	37%	35%

Short-Term Investments - Summar

Short-Term Investments - Summary of Marketable securities (Detail) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Schedule of short term investments [Line Items]
Amortized Cost	$ 402,135	$ 379,253
Gross Unrealized Gains	153	495
Gross Unrealized Losses	(753)	(615)
Estimated Fair Value	401,535	379,133
Certificates of deposit [Member]
Schedule of short term investments [Line Items]
Amortized Cost	2,467	2,455
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(11)	(21)
Estimated Fair Value	2,456	2,434
Commercial paper [Member]
Schedule of short term investments [Line Items]
Amortized Cost	4,147	8,927
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(3)	(6)
Estimated Fair Value	4,144	8,921
Corporate debt securities [Member]
Schedule of short term investments [Line Items]
Amortized Cost	161,396	162,515
Gross Unrealized Gains	95	234
Gross Unrealized Losses	(261)	(302)
Estimated Fair Value	161,230	162,447
Municipal securities [Member]
Schedule of short term investments [Line Items]
Amortized Cost	17,722	22,263
Gross Unrealized Gains	1	9
Gross Unrealized Losses	(49)	(36)
Estimated Fair Value	17,674	22,236
Government and agency debt [Member]
Schedule of short term investments [Line Items]
Amortized Cost	216,403	183,093
Gross Unrealized Gains	57	252
Gross Unrealized Losses	(429)	(250)
Estimated Fair Value	$ 216,031	$ 183,095

Short-Term Investments - Summ_2

Short-Term Investments - Summary of Company's Marketable Securities by Contractual Maturities (Details) $ in Thousands	Mar. 31, 2024 USD ($)
Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract]
Due in 1 year or less	$ 254,895
Due in 1 year through 2 years	146,640
Total	$ 401,535

Short-Term Investments - Summ_3

Short-Term Investments - Summary of Presents Fair Value and Gross Unrealized Losses of the Company's Marketable Securities (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]
Fair Value, Less Than 12 Months	$ 265,808	$ 192,501
Gross Unrealized Losses, Less Than 12 Months	(618)	(370)
Fair Value, 12 Months or Greater	39,798	40,518
Gross Unrealized Losses, 12 Months or Greater	(135)	(245)
Debt Securities, Available-for-Sale, Unrealized Loss Position	305,606	233,019
Gross Unrealized Losses	(753)	(615)
Certificates of deposit [Member]
Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]
Fair Value, Less Than 12 Months	250	250
Gross Unrealized Losses, Less Than 12 Months	(1)	0
Fair Value, 12 Months or Greater	2,206	2,175
Gross Unrealized Losses, 12 Months or Greater	(10)	(21)
Debt Securities, Available-for-Sale, Unrealized Loss Position	2,456	2,425
Gross Unrealized Losses	(11)	(21)
Commercial paper [Member]
Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]
Fair Value, Less Than 12 Months	4,144	8,921
Gross Unrealized Losses, Less Than 12 Months	(3)	(6)
Fair Value, 12 Months or Greater	0	0
Gross Unrealized Losses, 12 Months or Greater	0	0
Debt Securities, Available-for-Sale, Unrealized Loss Position	4,144	8,921
Gross Unrealized Losses	(3)	(6)
Corporate debt securities [Member]
Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]
Fair Value, Less Than 12 Months	102,475	77,023
Gross Unrealized Losses, Less Than 12 Months	(218)	(177)
Fair Value, 12 Months or Greater	14,347	25,156
Gross Unrealized Losses, 12 Months or Greater	(43)	(125)
Debt Securities, Available-for-Sale, Unrealized Loss Position	116,822	102,179
Gross Unrealized Losses	(261)	(302)
Municipal securities [Member]
Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]
Fair Value, Less Than 12 Months	11,814	7,071
Gross Unrealized Losses, Less Than 12 Months	(30)	(6)
Fair Value, 12 Months or Greater	4,576	4,215
Gross Unrealized Losses, 12 Months or Greater	(19)	(30)
Debt Securities, Available-for-Sale, Unrealized Loss Position	16,390	11,286
Gross Unrealized Losses	(49)	(36)
Government and agency debt [Member]
Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]
Fair Value, Less Than 12 Months	147,125	99,236
Gross Unrealized Losses, Less Than 12 Months	(366)	(181)
Fair Value, 12 Months or Greater	18,669	8,972
Gross Unrealized Losses, 12 Months or Greater	(63)	(69)
Debt Securities, Available-for-Sale, Unrealized Loss Position	165,794	108,208
Gross Unrealized Losses	$ (429)	$ (250)

Short-Term Investments - Additi

Short-Term Investments - Additional Information (Detail) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Marketable Securities [Table]
Short-term investments	$ 508,229	$ 460,245
Allowance for Credit Loss	0	0
Bank deposits
Marketable Securities [Table]
Short-term investments	$ 106,700	$ 81,100

Fair Value Measurements - Summa

Fair Value Measurements - Summary of Fair Value by Balance Sheet Grouping (Detail) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Marketable securities	$ 401,535	$ 379,133
Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash equivalents	32,037	40,646
Total financial assets	32,037	40,646
Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash equivalents		5,498
Marketable securities	401,535	379,133
Total financial assets	402,248	386,067
Total financial liabilities	702	57
Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash equivalents	32,037	46,144
Marketable securities	401,535	379,133
Total financial assets	434,285	426,713
Total financial liabilities	702	57
Prepaid Expenses and Other Current Assets [Member] | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Restricted bank deposits included in assets	12	12
Prepaid Expenses and Other Current Assets [Member] | Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Restricted bank deposits included in assets	12	12
Prepaid Expenses and Other Current Assets [Member] | Designated as Hedging Instrument [Member] | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Foreign currency contract, asset, fair value disclosure	666	1,189
Prepaid Expenses and Other Current Assets [Member] | Designated as Hedging Instrument [Member] | Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Foreign currency contract, asset, fair value disclosure	666	1,189
Prepaid Expenses and Other Current Assets [Member] | Not Designated as Hedging Instrument [Member] | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Foreign currency contract, asset, fair value disclosure	35	235
Prepaid Expenses and Other Current Assets [Member] | Not Designated as Hedging Instrument [Member] | Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Foreign currency contract, asset, fair value disclosure	35	235
Accrued Expenses And Other Current Liabilites [Member] | Designated as Hedging Instrument [Member] | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Foreign currency contracts, liability, fair value disclosure	255	52
Accrued Expenses And Other Current Liabilites [Member] | Designated as Hedging Instrument [Member] | Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Foreign currency contracts, liability, fair value disclosure	255	52
Accrued Expenses And Other Current Liabilites [Member] | Not Designated as Hedging Instrument [Member] | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Foreign currency contracts, liability, fair value disclosure	447	5
Accrued Expenses And Other Current Liabilites [Member] | Not Designated as Hedging Instrument [Member] | Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Foreign currency contracts, liability, fair value disclosure	447	5
Money market funds | Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash equivalents	32,037	40,646
Money market funds | Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash equivalents	32,037	40,646
Certificates of deposit | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Marketable securities	2,456	2,434
Certificates of deposit | Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Marketable securities	2,456	2,434
Commercial paper | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Marketable securities	4,144	8,921
Commercial paper | Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Marketable securities	4,144	8,921
Corporate debt securities | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Marketable securities	161,230	162,447
Corporate debt securities | Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Marketable securities	161,230	162,447
Municipal securities | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Marketable securities	17,674	22,236
Municipal securities | Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Marketable securities	17,674	22,236
Government and agency debt | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash equivalents		5,498
Marketable securities	216,031	183,095
Government and agency debt | Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash equivalents		5,498
Marketable securities	$ 216,031	$ 183,095

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Detail) - Level 3 - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total financial assets	$ 0	$ 0
Total financial liabilities	$ 0	$ 0

Derivative Financial Instrume_3

Derivative Financial Instruments and Hedging - Disclosure of Notional Amount of Derivatives By Hedging Designation (Detail) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Derivatives, Fair Value [Line Items]
Total derivative instruments	$ 76,542	$ 65,234
Foreign currency contracts [Member] | Derivatives designated as hedging instruments [Member]
Derivatives, Fair Value [Line Items]
Total derivative instruments	57,022	46,331
Foreign currency contracts [Member] | Derivatives not designated as hedging instruments [Member]
Derivatives, Fair Value [Line Items]
Total derivative instruments	$ 19,520	$ 18,903

Derivative Financial Instrume_4

Derivative Financial Instruments and Hedging - Derivative Instruments, Gain (Loss) (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Derivatives designated as hedging instruments [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Total gains (losses) recognized in earnings	$ 304	$ (1,108)
Derivatives not designated as hedging instruments [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Total gains (losses) recognized in earnings	(223)	(405)
Foreign Currency Contracts [Member] | Derivatives designated as hedging instruments [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Total gains (losses) recognized in earnings	$ 0	$ 0
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Nonoperating Income (Expense)	Nonoperating Income (Expense)
Foreign Currency Contracts [Member] | Derivatives not designated as hedging instruments [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Total gains (losses) recognized in earnings	$ (223)	$ (405)
Foreign Currency Contracts [Member] | Subscription–self-managed and SaaS [Member] | Derivatives designated as hedging instruments [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Total gains (losses) recognized in earnings	$ 20	$ (87)
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Cost of Revenue	Cost of Revenue
Foreign Currency Contracts [Member] | Research and development [Member] | Derivatives designated as hedging instruments [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Total gains (losses) recognized in earnings	$ 187	$ (688)
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Research and Development Expense	Research and Development Expense
Foreign Currency Contracts [Member] | Sales and marketing [Member] | Derivatives designated as hedging instruments [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Total gains (losses) recognized in earnings	$ 46	$ (152)
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Selling and Marketing Expense	Selling and Marketing Expense
Foreign Currency Contracts [Member] | General and administrative [Member] | Derivatives designated as hedging instruments [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Total gains (losses) recognized in earnings	$ 51	$ (181)
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	General and Administrative Expense	General and Administrative Expense

Condensed Consolidated Balanc_5

Condensed Consolidated Balance Sheet Components - Summary of Property and Equipment (Detail) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 18,955	$ 18,234
Less: accumulated depreciation and amortization	(12,482)	(11,571)
Property and equipment, net	6,473	6,663
Computer and software [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	9,655	9,030
Furniture and office equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	3,188	3,135
Leasehold improvements [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 6,112	$ 6,069

Condensed Consolidated Balanc_6

Condensed Consolidated Balance Sheet Components - Summary of Accrued Expenses and Other Current Liabilities (Detail) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Balance Sheet Related Disclosures [Abstract]
Accrued compensation and benefits	$ 22,724	$ 25,166
Accrued expenses	16,873	10,649
Accrued expenses and other current liabilities	$ 39,597	$ 35,815

Intangible Assets, Net - Summar

Intangible Assets, Net - Summary of Intangible Assets (Detail) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Intangible Assets [Line items]
Gross Carrrying Amount	$ 57,020	$ 57,020
Accumulated Amortization	(34,141)	(31,252)
Net Carrying Amount	22,879	25,768
Developed technology [Member]
Intangible Assets [Line items]
Gross Carrrying Amount	50,347	50,347
Accumulated Amortization	(30,310)	(27,779)
Net Carrying Amount	$ 20,037	$ 22,568
Weighted- Average Remaining Useful Life	2 years 1 month 6 days	2 years 3 months 18 days
Customer relationships [Member]
Intangible Assets [Line items]
Gross Carrrying Amount	$ 5,541	$ 5,541
Accumulated Amortization	(3,023)	(2,786)
Net Carrying Amount	$ 2,518	$ 2,755
Weighted- Average Remaining Useful Life	2 years 10 months 24 days	3 years 1 month 6 days
Other intangible assets [Member]
Intangible Assets [Line items]
Gross Carrrying Amount	$ 1,132	$ 1,132
Accumulated Amortization	(808)	(687)
Net Carrying Amount	$ 324	$ 445
Weighted- Average Remaining Useful Life	8 months 12 days	10 months 24 days

Intangible Assets, Net - Additi

Intangible Assets, Net - Additional Information (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Intangible Assets [Line items]
Amortization expenses for intangible assets	$ 2.9	$ 3

Intangible Assets, Net - Summ_2

Intangible Assets, Net - Summary of Expected Future Amortization Expenses by Year Related to the Intangible Assets (Detail) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
2024 (Remainder)	$ 8,145
2025	9,110
2026	5,241
2027	383
Net Carrying Amount	$ 22,879	$ 25,768

Leases - Components of Operatin

Leases - Components of Operating Lease Expense (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Lease, Cost [Abstract]
Operating lease cost	$ 2,275	$ 2,181
Short-term lease cost	176	112
Variable lease cost	103	96
Total operating lease cost	$ 2,554	$ 2,389

Leases - Additional Information

Leases - Additional Information (Detail)	Mar. 31, 2024
Lessee, Lease, Description [Line Items]
Operating Lease, Weighted Average Remaining Lease Term	3 years 4 months 24 days
Operating Lease, Weighted Average Discount Rate, Percent	2.70%

Leases - Supplemental Cash Flow

Leases - Supplemental Cash Flow Information Related to Operating Lease (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Leases [Abstract]
Cash paid for operating leases	$ 2,288	$ 1,896
ROU assets obtained in exchange for new operating lease liabilities	$ 0	$ 2,867

Leases - Schedule of Maturities

Leases - Schedule of Maturities of Operating Lease Liabilities (Detail) $ in Thousands	Mar. 31, 2024 USD ($)
Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]
2024 (Remainder)	$ 6,518
2025	7,884
2026	4,649
2027	1,616
2028	156
Total operating lease payments	20,823
Less: imputed interest	(983)
Total operating lease liabilities	$ 19,840

Commitments and Contingencies -

Commitments and Contingencies - Summary of Outstanding Non-cancelable Purchase Obligations (Detail) $ in Thousands	Mar. 31, 2024 USD ($)
Commitments and Contingencies Disclosure [Abstract]
2024 (Remainder)	$ 4,996
2025	16,980
2026	2,600
2027	25
2028	25
Total	$ 24,626

Commitments and Contingencies_2

Commitments and Contingencies - Additional Information (Detail) $ in Millions	3 Months Ended
	Mar. 31, 2024 USD ($)
Grants [Member] | Israeli Innovation Authority [Member]
Maximum additional payments as a grant recipient	$ 6

Shareholders' Equity and Equi_3

Shareholders' Equity and Equity Incentive Plans - Additional Information (Detail) - USD ($) $ in Millions		3 Months Ended
	Jan. 01, 2024	Mar. 31, 2024
Unrecognized share-based compensation cost		$ 237.5
Unrecognized share based compensation cost expected to be recognised period		2 years 8 months 12 days
2020 Plan [Member]
Share-based payment arrangement, increase of authorized shares	6,070,667
Employee Share Purchase Plan [Member]
Share-based payment arrangement, increase of authorized shares	1,061,148
Restricted Stock Units (RSUs) [Member]
Fair value of RSU		$ 34.1

Shareholders' Equity and Equi_4

Shareholders' Equity and Equity Incentive Plans - Summary of Stock Option Activity (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]
Outstanding Share Options, Beginning balance	5,110,390
Outstanding Share Options, Exercised	(1,280,624)
Outstanding Share Options, Forfeited	(9,900)
Outstanding Share Options, Ending balance	3,819,866	5,110,390
Outstanding Share Options, Exercisable	3,294,042
Weighted Average Exercise Price Per Share, Beginning balance	$ 8.49
Weighted Average Exercise Price Per Share, Exercised	5.27
Weighted Average Exercise Price Per Share, Forfeited	12.61
Weighted Average Exercise Price Per Share, Ending balance	9.57	$ 8.49
Weighted Average Exercise Price Per Share, Exercisable	$ 8.11
Weighted Average Remaining Contractual Life	4 years 6 months	4 years 1 month 6 days
Weighted Average Remaining Contractual Life, Exercisable	4 years 3 months 18 days
Aggregate Intrinsic Value, Beginning balance	$ 134,171
Aggregate Intrinsic Value, Exercised	46,905
Aggregate Intrinsic Value, Ending balance	132,808	$ 134,171
Aggregate Intrinsic Value, Exercisable	$ 119,216

Shareholders' Equity and Equi_5

Shareholders' Equity and Equity Incentive Plans - Summary of Restricted Ordinary Shares (Detail) - Restricted Stock Units (RSUs) [Member]	3 Months Ended
	Mar. 31, 2024 $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Unvested RSUs, Beginning balance | shares	10,006,997
Unvested RSUs, Granted | shares	777,826
Unvested RSUs, Vested | shares	(764,873)
Unvested RSUs, Forfeited | shares	(239,450)
Unvested RSUs, Ending balance | shares	9,780,500
Weighted Average Grant Date Fair Value Per Share, Beginning balance | $ / shares	$ 25.91
Weighted Average Grant Date Fair Value Per Share, Granted | $ / shares	35.67
Weighted Average Grant Date Fair Value Per Share, Vested | $ / shares	25.52
Weighted Average Grant Date Fair Value Per Share, Canceled/Forfeited | $ / shares	25.37
Weighted Average Grant Date Fair Value Per Share, Ending balance | $ / shares	$ 26.75

Shareholders' Equity and Equi_6

Shareholders' Equity and Equity Incentive Plans - Summary of Ordinary Shares Reserved for Future Issuance (Detail)	Mar. 31, 2024 shares
Class of Stock [Line Items]
Common Stock Reserved for Future Issuance	38,522,448
2020 Plan [Member]
Class of Stock [Line Items]
Common Stock Reserved for Future Issuance	19,757,175
Employee Stock Purchase Plan [Member]
Class of Stock [Line Items]
Common Stock Reserved for Future Issuance	5,164,907
Employee Stock Option
Class of Stock [Line Items]
Common Stock Reserved for Future Issuance	3,819,866
Restricted Stock Units (RSUs) [Member]
Class of Stock [Line Items]
Common Stock Reserved for Future Issuance	9,780,500

Shareholders' Equity and Equi_7

Shareholders' Equity and Equity Incentive Plans - Summary of Stock-based Compensation Expense (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-based compensation expense	$ 27,286	$ 19,912
Cost of revenue [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-based compensation expense	3,092	2,196
Research and development [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-based compensation expense	9,667	7,172
Sales and marketing [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-based compensation expense	9,813	6,473
General and administrative [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-based compensation expense	$ 4,714	$ 4,071

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Income (Loss) - Summary of Changes In AOCI (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Changes in Accumulated Other Comprehensive Income [Line items]
Beginning Balance	$ 1,013	$ (2,772)
Other comprehensive income (loss) before reclassifications	(850)	(870)
Net realized (gains) losses reclassified from AOCI	(307)	1,269
Other comprehensive income (loss), net of tax	(1,157)	399
Ending Balance	(144)	(2,373)
Net Unrealized Losses on Available-for-Sale Marketable Securities [Member]
Changes in Accumulated Other Comprehensive Income [Line items]
Beginning Balance	(124)	(1,694)
Other comprehensive income (loss) before reclassifications	(428)	411
Net realized (gains) losses reclassified from AOCI	(3)	161
Other comprehensive income (loss), net of tax	(431)	572
Ending Balance	(555)	(1,122)
Net Unrealized Gains(losses) on Derivatives Designated as Hedging Instruments [Member]
Changes in Accumulated Other Comprehensive Income [Line items]
Beginning Balance	1,137	(1,078)
Other comprehensive income (loss) before reclassifications	(422)	(1,281)
Net realized (gains) losses reclassified from AOCI	(304)	1,108
Other comprehensive income (loss), net of tax	(726)	(173)
Ending Balance	$ 411	$ (1,251)

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Income tax expense (benefit)	$ (759)	$ 1,588
Unrecognized tax benefits	$ 5,400		$ 5,400

Net Loss Per Share - Summary of

Net Loss Per Share - Summary of Computation of Basic and Diluted Net Loss Per Share (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Numerator:
Net loss	$ (8,790)	$ (20,809)
Denominator:
Weighted-average shares used in computing net loss per share, basic	107,025,351	101,260,549
Weighted-average shares used in computing net loss per share, diluted	107,025,351	101,260,549
Net loss per share, basic	$ (0.08)	$ (0.21)
Net loss per share, diluted	$ (0.08)	$ (0.21)

Net Loss Per Share - Summary _2

Net Loss Per Share - Summary of Shares Excluded From the Computation of Diluted Net Loss Per Share (Detail) - shares	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares excluded from computation of diluted net loss per share	14,777,568	15,330,350
Outstanding share options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares excluded from computation of diluted net loss per share	4,543,485	7,025,265
Unvested RSUs [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares excluded from computation of diluted net loss per share	10,073,530	8,052,284
Share purchase rights under the ESPP [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares excluded from computation of diluted net loss per share	160,553	197,335
Issuable ordinary shares related to business combination [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares excluded from computation of diluted net loss per share	0	55,466